UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 2, 2012
CareFusion Corporation
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| 001-34273 | 26-4123274 | |||
| (Commission File Number) | (IRS Employer Identification Number) |
3750 Torrey View Court, San Diego, California 92130
(Address of Principal Executive Offices, Including Zip Code)
(858) 617-2000
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 7.01 | Regulation FD Disclosure |
On June 27, 2012, CareFusion Corporation (the “Company”) began notifying customers of a voluntary recall affecting the PC unit of certain of its Alaris® infusion pumps. The Company has identified a potential risk associated with the Alaris PC unit model 8015 manufactured or serviced after January 2011 related to the power supply board. In certain cases, a component on the PC unit power supply board can malfunction, which causes an error code and triggers an audible alarm and visual error message on the PC unit screen. The Company is working with its customers to repair the power supply board. Based on current estimates for this work and adjustments to the Company’s reserve associated with other product recalls, the Company expects to increase its total recall reserve by approximately $7 million for the quarter and fiscal year ended June 30, 2012.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CareFusion Corporation | ||||||
| (Registrant) | ||||||
| Date: July 2, 2012 | By: | /s/ Joan Stafslien | ||||
| Name: | Joan Stafslien | |||||
| Title: | Executive Vice President, Chief Compliance Officer, General Counsel and Secretary | |||||